These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

33 related items for PubMed ID: 7712686

  • 1. Pancreatic reserve and insulin dose in type 2 diabetic patients.
    Calle JR, Rubio MA, Calle-Pascual AL, Bordiu E, Marañés JP.
    Diabetes Res; 1993; 23(3):123-9. PubMed ID: 7712686
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The utility of postprandial C-peptide evaluation in type 2 diabetes].
    Prando R, Giusti R, Ciuchi E, Giusto M, Melga PL, Cheli V.
    Riv Eur Sci Med Farmacol; 1996; 18(3):95-104. PubMed ID: 9213846
    [Abstract] [Full Text] [Related]

  • 4. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
    Rattarasarn C, Thamprasit A, Leelawattana R, Soonthornpun S, Setasuban W.
    J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
    [Abstract] [Full Text] [Related]

  • 5. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C, Ramachandran A, Mohan V, Timothy H, Viswanathan M.
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O, Ertorer ME, Bozkirli E, Tutuncu NB, Demirag NG.
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS, Draeger KE, van Iperen AM, Martini C, Aarsen M, Heine RJ.
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R, Müller UA, Rauchfub J, Sprott H, Müller R.
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C, Ramachandran A, Mohan V, Viswanathan M.
    Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A, Velasco N, Szegedi AM, Pellegrino MR, López G, Foradori A, Acosta AM.
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.